Trump Unveils Healthcare Framework as ACA Credits Stall

Donald Trump rolled out what he's calling the "Great Healthcare Plan," a framework designed to bring down prescription drug costs and insurance premiums. The timing matters because Senate efforts to extend key Affordable Care Act tax credits have hit a wall, which could mean higher premiums for millions. The White House is framing this as direct cost relief, not another round of insurer subsidies.

Here's what's in it: most-favored-nation pricing for prescription drugs, expanded direct-to-consumer discounted drug sales, and a shift that redirects insurance funding to individuals instead of insurers. There are also cost-sharing reductions that could drop premiums on common Obamacare plans by more than 10%, plus broader price-transparency requirements. Politically, it checks a lot of boxes. Whether it actually happens is another question.

The U.S.-Taiwan Chip Agreement Reshapes Trade Policy

The U.S. and Taiwan just locked in a trade agreement focused on expanding semiconductor manufacturing on American soil. Taiwanese chip companies committed at least $250 billion in U.S. investment, backed by $250 billion in credit guarantees from the U.S. government. In return, the U.S. agreed to cap tariffs at 15%, remove certain duties, and grant Section 232 national security exemptions for U.S.-based fabrication plants.

TSMC has already bought land in Arizona and may expand further, with new flexibility to import equipment tariff-free during construction. This deal smooths out supply-chain friction and aligns industrial policy with long-term capacity building. For markets, it takes a meaningful chunk of uncertainty off the table around large-scale capital expenditures.

TSMC Earnings Show AI Capex Is Here to Stay

TSMC crushed fourth-quarter expectations, reporting NT$505.7 billion in net profit, up 35% year over year, driven by strong AI demand. The real headline was the $52-56 billion capex forecast, well above what analysts expected and a clear indicator that AI investment isn't a short-term fad. Semiconductor equipment makers like ASML rallied on the news.

Management guided to roughly 30% revenue growth and confirmed its position as the primary chip supplier to NVIDIA. Add in the expanding U.S. operations, and the message is straightforward: AI infrastructure spending is becoming a permanent fixture, not a cyclical trade.